Literature DB >> 491501

[Effect of caerulein on the exocrine pancreas function in man; examinations of dose effects and comparisons with the effect of cholecystokinin/pankreozymin (author's transl)].

M Otte, M M Forell.   

Abstract

The purpose of the study was to examine the secretory response of the exocrine pancreas in man to various doses of the synthesised decapeptide Caerulein (Takus), 5, 10 and 20 ng/kg Caerulein injected intravenously during an infusion of 0,5 CU/kg/h Secretin (GIH) produced a linear increase of enzyme secretion (amylase, lipase, trypsin and chymotrypsin) and also an increase in the water and bicarbonate secretion of the pancreas which is induced by Secretin. The injection of 40 ng/kg Caerulein led to no further increase of the ecbolic function. The intravenous injection of 1 Ivy dog unit (IDU/kg and 20 and 40 ng/kg Caerulein have an identical effect on the exocrine pancreas, there were no statistic differences.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 491501     DOI: 10.1007/bf01478037

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  12 in total

1.  Pancreatic secretion of total protein and of three hydrolases collected in healthy subjects via duodenoscopic cannulation. Effects of secretin, pancreozymin, and caerulein.

Authors:  P Robberecht; M Cremer; A Vandermeers; M C Vandermeers-Piret; P Cotton; P De Neef; J Christophe
Journal:  Gastroenterology       Date:  1975-08       Impact factor: 22.682

2.  Improved method for the bedside determination of bicarbonate in serum.

Authors:  B H SCRIBNER; J C CAILLOUETTE
Journal:  J Am Med Assoc       Date:  1954-06-12

3.  The role of caerulein in tests of exocrine pancreatic function.

Authors:  G Cavallini; R Mirachian; G Angelini; I Vantini; B Vaona; P Bovo; F Gelpi; A Ederle; G Dobrilla; L A Scuro
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

4.  [Pancreatic secretion in man after stimulation with cholecystokinin-pancreozymin, secretin and bile. Methods and normal ranges (author's transl)].

Authors:  M Otte; H Stahlheber; M Zoelch; M M Forell; G R Thurmayr; R Thurmayr
Journal:  Klin Wochenschr       Date:  1973-09-15

5.  [Initial results with caerulein in pancreatic function tests in man].

Authors:  S Bonfils; J Gislon; J L Junien
Journal:  Acta Gastroenterol Belg       Date:  1971-01       Impact factor: 1.316

6.  Augmentation of secretin-induced pancreatic secretion by caerulein.

Authors:  S J Konturek; J Biernat; T Grzelec
Journal:  Am J Dig Dis       Date:  1972-07

7.  Cholecystokinetic activity of the new peptide caerulein in man.

Authors:  G Bertaccini; T Braibanti; F Uva
Journal:  Gastroenterology       Date:  1969-05       Impact factor: 22.682

8.  Isolation and structure of caerulein, an active decapeptide from the skin of Hyla caerulea.

Authors:  A Anastasi; V Erspamer; R Endean
Journal:  Experientia       Date:  1967-09-15

9.  Use of caerulein with submaximal doses of secretin as a test of pancreatic function in man.

Authors:  A Ribet; R Tournut; M Duffaut; N Vaysse
Journal:  Gut       Date:  1976-06       Impact factor: 23.059

10.  Comparison of caerulein and cholecystokinin effects upon enzyme concentrations in duodenal aspirates.

Authors:  Y Minaire; L Descos
Journal:  Digestion       Date:  1977       Impact factor: 3.216

View more
  1 in total

1.  [Effect of caerulein on blood glucose, serum insulin, glucagon, prolactin and growth hormone before and after oral glucose load in healthy volunteers and diabetic patients (author's transl)].

Authors:  R Landgraf; T Eversmann; M M Landgraf-Leurs
Journal:  Klin Wochenschr       Date:  1981-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.